electroCore, Inc. (ECOR)
NASDAQ: ECOR · Real-Time Price · USD
11.21
+1.29 (13.00%)
At close: Nov 22, 2024, 4:00 PM
11.30
+0.09 (0.80%)
After-hours: Nov 22, 2024, 4:39 PM EST
electroCore Revenue
electroCore had revenue of $6.55M in the quarter ending September 30, 2024, with 45.39% growth. This brings the company's revenue in the last twelve months to $23.33M, up 74.10% year-over-year. In the year 2023, electroCore had annual revenue of $16.03M with 86.57% growth.
Revenue (ttm)
$23.33M
Revenue Growth
+74.10%
P/S Ratio
3.41
Revenue / Employee
$343,044
Employees
68
Market Cap
72.27M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CytomX Therapeutics | 126.62M |
OptiNose | 75.67M |
Exagen | 55.75M |
Metagenomi | 55.08M |
bluebird bio | 53.12M |
InspireMD | 6.82M |
BeyondSpring | 1.88M |
Vistagen Therapeutics | 876.00K |
ECOR News
- 8 days ago - electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21 - GlobeNewsWire
- 9 days ago - electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - electroCore Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 10 days ago - ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award - GlobeNewsWire
- 14 days ago - electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - electroCore to Participate at LD Micro Main Event VXII - Newsfile Corp
- 2 months ago - Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training - GlobeNewsWire
- 2 months ago - electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire